Patent delisted for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA. […]
Patent Expiration
Patent delisted for IMPAX drug TWINJECT 0.3
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
Patent delisted for Teva Pharms drug COPAXONE
Annual Drug Patent Expirations for COPAXONE Copaxone is a drug marketed by Teva Pharms Usa and is included in one
Patent delisted for Merck Sharp drug PREVYMIS
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Patent delisted for Boehringer Ingelheim drug JARDIANCE
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Patent delisted for Purdue Pharma drug TARGINIQ
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one
Patent delisted for Boehringer Ingelheim drug OFEV
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Patent delisted for Boehringer Ingelheim drug GLYXAMBI
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
